Holen Sie sich die Stockscreener-App
20.07
2.43%
-0.50
Finanzdaten der Faeth Therapeutics Inc-Aktie (FTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
89.23%
18.39
|
170.63 | 4.957 | 4.851 | 5.206 |
| Operating Income/Loss |
89.23%
-18.39
|
-170.63 | -4.957 | -4.851 | -5.206 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
90.60%
-16.01
|
-170.24 | -4.717 | -4.569 | -4.936 |
| Basic Average Shares |
335.75%
5.6432
|
1.2951 | - | 1.2613 | 1.2609 |
| Diluted Average Shares |
335.75%
5.6432
|
1.2951 | - | 1.2613 | 1.2609 |
| Basic Earnings Per Share |
97.84%
-2.84
|
-131.45 | - | -3.62 | -3.91 |
| Diluted Earnings Per Share |
97.84%
-2.84
|
-131.45 | - | -3.62 | -3.91 |
0.85%
3.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):